2023-07-17 | Savara Inc. SVRA | 10 percent owner | 333,333 0.2084% | $3.00 | $999,999 | +32.01% | ||
2021-10-18 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 1.85M 11.1305% | $1.62 | $3M | +63.35% | ||
2021-06-28 | Monte Rosa Therapeutics, Inc. GLUE | 10 percent owner | 1.05M 20.5778% | $19.00 | $19.95M | -7.95% | ||
2021-03-16 | Marker Therapeutics, Inc. MRKR | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.3% | ||
2020-12-31 | Sale | Allakos Inc. ALLK | director | 70,046 0.1321% | $140.46 | $9.84M | -28.14% | |
2020-12-30 | Sale | Allakos Inc. ALLK | director | 136,784 0.2667% | $141.71 | $19.38M | -28.63% | |
2020-12-04 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 4.4M 7.578% | $0.62 | $2.74M | +22.37% | ||
2020-04-03 | Sale | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 1,128 0.0062% | $2.66 | $3,000 | +19.07% | |
2019-07-22 | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 900,000 5.3814% | $15.00 | $13.5M | +5.09% | ||
2019-05-09 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 5M 34.6117% | $10.00 | $50M | -42.9% | ||
2019-05-07 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 1.14M 6.1239% | $1.08 | $1.23M | -40% |